UPLOAD Filing
Whitehawk Therapeutics, Inc.
Date: May 22, 2025 · CIK: 0001422142 · Accession: 0000000000-25-005482
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38560
Letter
Re: Whitehawk Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-38560 Dear Scott Giacobello:
May 22, 2025
Scott Giacobello Chief Financial Officer Whitehawk Therapeutics, Inc. 2 Headquarters Plaza East Building 11th Floor Morristown, NJ 07960
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 22, 2025 Scott Giacobello Chief Financial Officer Whitehawk Therapeutics, Inc. 2 Headquarters Plaza East Building 11th Floor Morristown, NJ 07960 Re: Whitehawk Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-38560 Dear Scott Giacobello: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>